+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Insomnia Drugs - Market Analysis, Trends, and Forecasts

  • ID: 4805472
  • Report
  • 147 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Astellas Pharma
  • Eisai Co., Ltd.
  • Flynn Pharma Limited
  • Johnson & Johnson
  • Meda Ab
  • Merck & Co.
  • MORE
The Insomnia Drugs market worldwide is projected to grow by US$1.1 Billion, driven by a compounded growth of 5.2%. Prescription Sleep Aids, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.1 Billion by the year 2025, Prescription Sleep Aids will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$40 Million to the region's size and clout in the next 5 to 6 years. Over US$33.2 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Prescription Sleep Aids will reach a market size of US$178.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 8.2% over the next couple of years and add approximately US$334.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Astellas Pharma, Inc.
  • Eisai Co., Ltd.
  • Flynn Pharma Limited
  • Johnson & Johnson
  • Meda AB
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Sanofi
  • Takeda Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astellas Pharma
  • Eisai Co., Ltd.
  • Flynn Pharma Limited
  • Johnson & Johnson
  • Meda Ab
  • Merck & Co.
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Insomnia Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Insomnia Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Insomnia Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Insomnia Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Prescription Sleep Aids (Segment) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Prescription Sleep Aids (Segment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Prescription Sleep Aids (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Over the Counter (OTC) Sleep Aids (Segment) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Over the Counter (OTC) Sleep Aids (Segment) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Over the Counter (OTC) Sleep Aids (Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Insomnia Drugs Market Share (in %) by Company: 2019 & 2025

TABLE 10: United States Insomnia Drugs Market Estimates and Projections in US$ Million by Segment: 2018 to 2025

TABLE 11: Insomnia Drugs Market in the United States by Segment: A Historic Review in US$ Million for 2009-2017

TABLE 12: United States Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

CANADA

TABLE 13: Canadian Insomnia Drugs Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025

TABLE 14: Canadian Insomnia Drugs Historic Market Review by Segment in US$ Million: 2009-2017

TABLE 15: Insomnia Drugs Market in Canada: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025

JAPAN

TABLE 16: Japanese Market for Insomnia Drugs: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025

TABLE 17: Insomnia Drugs Market in Japan: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017

TABLE 18: Japanese Insomnia Drugs Market Share Analysis by Segment: 2009 VS 2019 VS 2025

CHINA

TABLE 19: Chinese Insomnia Drugs Market Growth Prospects in US$ Million by Segment for the Period 2018-2025

TABLE 20: Insomnia Drugs Historic Market Analysis in China in US$ Million by Segment: 2009-2017

TABLE 21: Chinese Insomnia Drugs Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Insomnia Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 22: European Insomnia Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 23: Insomnia Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 24: European Insomnia Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: European Insomnia Drugs Market Estimates and Forecasts in US$ Million by Segment: 2018-2025

TABLE 26: Insomnia Drugs Market in Europe in US$ Million by Segment: A Historic Review for the Period 2009-2017

TABLE 27: European Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

FRANCE

TABLE 28: Insomnia Drugs Market in France by Segment: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 29: French Insomnia Drugs Historic Market Scenario in US$ Million by Segment: 2009-2017

TABLE 30: French Insomnia Drugs Market Share Analysis by Segment: 2009 VS 2019 VS 2025

GERMANY

TABLE 31: Insomnia Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025

TABLE 32: German Insomnia Drugs Historic Market Analysis in US$ Million by Segment: 2009-2017

TABLE 33: German Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

ITALY

TABLE 34: Italian Insomnia Drugs Market Growth Prospects in US$ Million by Segment for the Period 2018-2025

TABLE 35: Insomnia Drugs Historic Market Analysis in Italy in US$ Million by Segment: 2009-2017

TABLE 36: Italian Insomnia Drugs Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 37: United Kingdom Market for Insomnia Drugs: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025

TABLE 38: Insomnia Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017

TABLE 39: United Kingdom Insomnia Drugs Market Share Analysis by Segment: 2009 VS 2019 VS 2025

SPAIN

TABLE 40: Spanish Insomnia Drugs Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025

TABLE 41: Spanish Insomnia Drugs Historic Market Review by Segment in US$ Million: 2009-2017

TABLE 42: Insomnia Drugs Market in Spain: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025

RUSSIA

TABLE 43: Russian Insomnia Drugs Market Estimates and Projections in US$ Million by Segment: 2018 to 2025

TABLE 44: Insomnia Drugs Market in Russia by Segment: A Historic Review in US$ Million for 2009-2017

TABLE 45: Russian Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 46: Rest of Europe Insomnia Drugs Market Estimates and Forecasts in US$ Million by Segment: 2018-2025

TABLE 47: Insomnia Drugs Market in Rest of Europe in US$ Million by Segment: A Historic Review for the Period 2009-2017

TABLE 48: Rest of Europe Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 49: Asia-Pacific Insomnia Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 50: Insomnia Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 51: Asia-Pacific Insomnia Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 52: Insomnia Drugs Market in Asia-Pacific by Segment: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 53: Asia-Pacific Insomnia Drugs Historic Market Scenario in US$ Million by Segment: 2009-2017

TABLE 54: Asia-Pacific Insomnia Drugs Market Share Analysis by Segment: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 55: Insomnia Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025

TABLE 56: Australian Insomnia Drugs Historic Market Analysis in US$ Million by Segment: 2009-2017

TABLE 57: Australian Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

INDIA

TABLE 58: Indian Insomnia Drugs Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025

TABLE 59: Indian Insomnia Drugs Historic Market Review by Segment in US$ Million: 2009-2017

TABLE 60: Insomnia Drugs Market in India: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025

SOUTH KOREA

TABLE 61: Insomnia Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025

TABLE 62: South Korean Insomnia Drugs Historic Market Analysis in US$ Million by Segment: 2009-2017

TABLE 63: Insomnia Drugs Market Share Distribution in South Korea by Segment: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 64: Rest of Asia-Pacific Market for Insomnia Drugs: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025

TABLE 65: Insomnia Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017

TABLE 66: Rest of Asia-Pacific Insomnia Drugs Market Share Analysis by Segment: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 67: Latin American Insomnia Drugs Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 68: Insomnia Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 69: Latin American Insomnia Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 70: Latin American Insomnia Drugs Market Growth Prospects in US$ Million by Segment for the Period 2018-2025

TABLE 71: Insomnia Drugs Historic Market Analysis in Latin America in US$ Million by Segment: 2009-2017

TABLE 72: Latin American Insomnia Drugs Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 73: Argentinean Insomnia Drugs Market Estimates and Forecasts in US$ Million by Segment: 2018-2025

TABLE 74: Insomnia Drugs Market in Argentina in US$ Million by Segment: A Historic Review for the Period 2009-2017

TABLE 75: Argentinean Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

BRAZIL

TABLE 76: Insomnia Drugs Market in Brazil by Segment: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 77: Brazilian Insomnia Drugs Historic Market Scenario in US$ Million by Segment: 2009-2017

TABLE 78: Brazilian Insomnia Drugs Market Share Analysis by Segment: 2009 VS 2019 VS 2025

MEXICO

TABLE 79: Insomnia Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025

TABLE 80: Mexican Insomnia Drugs Historic Market Analysis in US$ Million by Segment: 2009-2017

TABLE 81: Mexican Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 82: Rest of Latin America Insomnia Drugs Market Estimates and Projections in US$ Million by Segment: 2018 to 2025

TABLE 83: Insomnia Drugs Market in Rest of Latin America by Segment: A Historic Review in US$ Million for 2009-2017

TABLE 84: Rest of Latin America Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 85: The Middle East Insomnia Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 86: Insomnia Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 87: The Middle East Insomnia Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 88: The Middle East Insomnia Drugs Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025

TABLE 89: The Middle East Insomnia Drugs Historic Market by Segment in US$ Million: 2009-2017

TABLE 90: Insomnia Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025

IRAN

TABLE 91: Iranian Market for Insomnia Drugs: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025

TABLE 92: Insomnia Drugs Market in Iran: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017

TABLE 93: Iranian Insomnia Drugs Market Share Analysis by Segment: 2009 VS 2019 VS 2025

ISRAEL

TABLE 94: Israeli Insomnia Drugs Market Estimates and Forecasts in US$ Million by Segment: 2018-2025

TABLE 95: Insomnia Drugs Market in Israel in US$ Million by Segment: A Historic Review for the Period 2009-2017

TABLE 96: Israeli Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 97: Saudi Arabian Insomnia Drugs Market Growth Prospects in US$ Million by Segment for the Period 2018-2025

TABLE 98: Insomnia Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Segment: 2009-2017

TABLE 99: Saudi Arabian Insomnia Drugs Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 100: Insomnia Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025

TABLE 101: United Arab Emirates Insomnia Drugs Historic Market Analysis in US$ Million by Segment: 2009-2017

TABLE 102: Insomnia Drugs Market Share Distribution in United Arab Emirates by Segment: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 103: Insomnia Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025

TABLE 104: Rest of Middle East Insomnia Drugs Historic Market Analysis in US$ Million by Segment: 2009-2017

TABLE 105: Rest of Middle East Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

AFRICA

TABLE 106: African Insomnia Drugs Market Estimates and Projections in US$ Million by Segment: 2018 to 2025

TABLE 107: Insomnia Drugs Market in Africa by Segment: A Historic Review in US$ Million for 2009-2017

TABLE 108: African Insomnia Drugs Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

IV. COMPETITION

ASTELLAS PHARMA

EISAI CO., LTD.

FLYNN PHARMA LIMITED

JOHNSON & JOHNSON

MEDA AB

MERCK & CO.

PFIZER

SANOFI SA

TAKEDA PHARMACEUTICAL COMPANY LIMITED

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astellas Pharma
  • Eisai Co., Ltd.
  • Flynn Pharma Limited
  • Johnson & Johnson
  • Meda Ab
  • Merck & Co.
  • Pfizer
  • Sanofi Sa
  • Takeda Pharmaceutical Company Limited
Note: Product cover images may vary from those shown
Adroll
adroll